News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
720,171 Results
Type
Article (64197)
Company Profile (286)
Press Release (655688)
Multimedia
Podcasts (100)
Webinars (13)
Section
Business (195970)
Career Advice (2869)
Deals (36245)
Drug Delivery (123)
Drug Development (83686)
Employer Resources (169)
FDA (16884)
Job Trends (15282)
News (342406)
Policy (34143)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (7)
2024 BioForest Standard (1)
2024 BioMidwest Digital (5)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (16)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (7)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (9)
2024 Pharm Country Digital (8)
2024 Pharm Country Standard (5)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2838)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (93)
Alliances (49470)
ALS (98)
Alzheimer's disease (1442)
Antibody-drug conjugate (ADC) (145)
Approvals (16856)
Artificial intelligence (289)
Autoimmune disease (28)
Automation (16)
Bankruptcy (337)
Best Places to Work (11928)
BIOSECURE Act (22)
Biosimilars (117)
Biotechnology (212)
Bladder cancer (83)
Brain cancer (31)
Breast cancer (299)
Cancer (2397)
Cardiovascular disease (197)
Career advice (2419)
Career pathing (33)
CAR-T (172)
Cell therapy (482)
Cervical cancer (21)
Clinical research (67835)
Collaboration (900)
Compensation (503)
Complete response letters (29)
COVID-19 (2758)
CRISPR (48)
C-suite (260)
Cystic fibrosis (107)
Data (2240)
Decentralized trials (2)
Denatured (33)
Depression (53)
Diabetes (284)
Diagnostics (6694)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (42)
Drug discovery (131)
Drug pricing (114)
Drug shortages (32)
Duchenne muscular dystrophy (101)
Earnings (73511)
Editorial (43)
Employer branding (22)
Employer resources (148)
Events (110638)
Executive appointments (769)
FDA (18179)
Featured Employer (53)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (793)
Gene editing (119)
Generative AI (25)
Gene therapy (354)
GLP-1 (779)
Government (4857)
Grass and pollen (6)
Guidances (58)
Healthcare (19849)
Huntington's disease (24)
IgA nephropathy (29)
Immunology and inflammation (141)
Indications (30)
Infectious disease (2909)
Inflammatory bowel disease (149)
Inflation Reduction Act (10)
Influenza (54)
Intellectual property (99)
Interviews (540)
IPO (16819)
IRA (40)
Job creations (3804)
Job search strategy (2028)
Kidney cancer (10)
Labor market (33)
Layoffs (539)
Leadership (23)
Legal (8226)
Liver cancer (77)
Lung cancer (343)
Lymphoma (157)
Machine learning (7)
Management (58)
Manufacturing (332)
MASH (70)
Medical device (13731)
Medtech (13736)
Mergers & acquisitions (20007)
Metabolic disorders (738)
Multiple sclerosis (85)
NASH (20)
Neurodegenerative disease (109)
Neuropsychiatric disorders (32)
Neuroscience (2028)
NextGen: Class of 2025 (6937)
Non-profit (4761)
Northern California (2653)
Now hiring (30)
Obesity (392)
Opinion (268)
Ovarian cancer (78)
Pain (93)
Pancreatic cancer (85)
Parkinson's disease (158)
Partnered (22)
Patents (248)
Patient recruitment (113)
Peanut (51)
People (61142)
Pharmaceutical (60)
Pharmacy benefit managers (21)
Phase I (21168)
Phase II (29738)
Phase III (22251)
Pipeline (1220)
Policy (145)
Postmarket research (2774)
Preclinical (9108)
Press Release (72)
Prostate cancer (113)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (425)
Real estate (6349)
Recruiting (68)
Regulatory (23310)
Reports (36)
Research institute (2533)
Resumes & cover letters (440)
Rett syndrome (5)
RNA editing (5)
RSV (47)
Schizophrenia (76)
Series A (141)
Series B (90)
Service/supplier (12)
Sickle cell disease (57)
Southern California (2303)
Special edition (15)
Spinal muscular atrophy (164)
Sponsored (31)
Startups (3648)
State (2)
Stomach cancer (16)
Supply chain (71)
Tariffs (35)
The Weekly (65)
United States (23424)
Vaccines (756)
Venture capitalists (42)
Weight loss (272)
Women's health (34)
Worklife (19)
Date
Today (148)
Last 7 days (910)
Last 30 days (2714)
Last 365 days (33939)
2025 (11053)
2024 (36178)
2023 (40795)
2022 (51970)
2021 (56810)
2020 (55455)
2019 (48578)
2018 (37009)
2017 (33918)
2016 (33363)
2015 (38972)
2014 (31910)
2013 (31028)
2012 (29413)
2011 (29695)
2010 (28032)
Location
Africa (960)
Alabama (55)
Alaska (7)
Arizona (197)
Arkansas (14)
Asia (42680)
Australia (7493)
California (6133)
Canada (1984)
China (552)
Colorado (268)
Connecticut (290)
Delaware (149)
Europe (98436)
Florida (919)
Georgia (210)
Idaho (61)
Illinois (568)
India (28)
Indiana (311)
Iowa (10)
Japan (164)
Kansas (104)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (904)
Massachusetts (4690)
Michigan (227)
Minnesota (404)
Mississippi (2)
Missouri (88)
Montana (31)
Nebraska (26)
Nevada (64)
New Hampshire (64)
New Jersey (1752)
New Mexico (31)
New York (1752)
North Carolina (1053)
North Dakota (9)
Northern California (2653)
Ohio (211)
Oklahoma (15)
Oregon (38)
Pennsylvania (1342)
Puerto Rico (13)
Rhode Island (31)
South America (1310)
South Carolina (19)
South Dakota (1)
Southern California (2303)
Tennessee (99)
Texas (912)
Utah (185)
Virginia (150)
Washington D.C. (58)
Washington State (562)
West Virginia (3)
Wisconsin (62)
720,171 Results for "paragon gene therapy a unit of catalent biologics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
Cell and Gene Therapy Sector Enters ‘Critical’ Period After Marks’ FDA Exit
As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene therapy space, experts express wariness over the unknowns and optimism that Marks’ legacy will carry on.
April 28, 2025
·
7 min read
·
Heather McKenzie
Gene therapy
Roche Absorbs $2.4B Impairment in Overhaul of Spark Gene Therapy Unit
Roche acquired Spark Therapeutics in 2019 for $4.8 billion.
March 11, 2025
·
2 min read
·
Tristan Manalac
In partnership with GenScript
Beyond the Breakthrough: Industry Leaders Address Key Hurdles Facing Cell and Gene Therapies
At the GenScript Biotech Global Forum 2025, industry leaders celebrated CAR T cell therapy achievements while discussing ongoing challenges in manufacturing, distribution, treatment center capacity, and global payment structures for cell and gene therapies.
April 14, 2025
·
6 min read
·
BioSpace Insights
Layoffs
Tenaya Slashes a Third of Workforce To Fund Development of Cardio Gene Therapies
The layoffs will take place throughout 2025 and will mostly affect Tenaya’s research and manufacturing operations. The company is continuing to test its hypertrophic cardiomyopathy gene therapy.
April 1, 2025
·
2 min read
·
Tristan Manalac
Gene therapy
Vertex Severs Liver Gene Therapies Partnership With Verve
The companies were two years into a four-year, $400 million agreement aimed at developing and marketing gene therapies together.
February 27, 2025
·
2 min read
·
Dan Samorodnitsky
IN PARTNERSHIP WITH CHARLES RIVER LABORATORIES
Cell and Gene Therapy Sector Sees 30% Investment Surge Despite Market Challenges
Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts explored at Charles River Laboratories’ 2025 Cell & Gene Therapy Summit.
March 31, 2025
·
5 min read
·
BioSpace Insights
Business
Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cancer
Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for Cancer, and Catalent Inc., the leader in enabling the development and supply of better treatments for patients worldwide, entered a strategic partnership to support the development and manufacturing of Siren Biotechnology’s AAV immuno-gene therapies.
May 8, 2024
·
2 min read
Gene therapy
Lexeo Plots Pivotal Path for Friedreich’s Ataxia Gene Therapy After ‘Compelling’ Phase I/II Data
Stifel analysts said that Lexeo’s data showing reduced size and thickness of the heart’s left ventricle are “supportive of a drug effect” for the company’s gene therapy in Friedreich’s ataxia cardiomyopathy.
April 8, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Adeno-associated Virus Gene Therapy Market Size to Reach USD 107.2 Billion by 2035, Impelled by Advancements in Personalized Medicine.
Adeno-associated Virus Gene Therapy Market Outlook 2025-2035:
February 17, 2025
·
11 min read
Press Releases
Zimmer Biomet Completes Acquisition of Paragon 28
April 21, 2025
·
6 min read
1 of 72,018
Next
